Literature DB >> 12417375

The pathology of ischemic-vascular dementia: an update.

Kurt A Jellinger1.   

Abstract

In Western memory clinic-based series, ischemic-vascular dementia (IVD) is seen in 8-10% of cognitively impaired elderly subjects. Its prevalence in autopsy series ranges from 0.03% to 58% with reasonable values of 4-10%, while in Japan, IVD is seen in 22-35% and mixed-type dementia (MTD) (Alzheimer disease/AD+IVD) in 6-11%. In a large Viennese autopsy series, "pure" IVD was observed in 9.4% of demented elderly and in 2.9% of those clinically diagnosed as possible/probable AD MTD was observed in 3.1% and 1.3% respectively. The major morphological types of IVD are multi-infarct encephalopathy (MIE), small vessel infarct type-strategic infarct dementia (SID), subcortical arteriosclerotic leukoencephalopathy (Binswanger), multilacunar state, mixed cortico-subcortical type, granular cortical atrophy, and post-ischemic encephalopathy. In contrast to previous suggestions that IVD is mainly the result of large hemispheral infarcts or losses of over 100 ml of brain tissue, recent data indicate that cognitive decline is commonly associated with widespread small ischemic or vascular lesions (microinfarcts, lacunes) throughout the brain with predominant involvement of the basal ganglia, white matter, and hippocampus. The lesion pattern of "pure" IVD, which is related to arteriolosclerosis and hypertensive microangiopathy, differs from that in mixed-type dementia, more often showing large infarcts. Although recent studies suggest that concomitant small cerebral infarcts do not significantly influence the overall rate of cognitive decline in AD patients or may be important for mental decline in early AD, both mild AD pathology and microvascular cerebral lesions appear to be common and may interact in "unmasking" or promoting dementia.

Entities:  

Mesh:

Year:  2002        PMID: 12417375     DOI: 10.1016/s0022-510x(02)00282-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  34 in total

Review 1.  Amyloid-β production: major link between oxidative stress and BACE1.

Authors:  Elena Tamagno; Michela Guglielmotto; Debora Monteleone; Massimo Tabaton
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

2.  Cerebrovascular blood flow velocities in pseudoexfoliation.

Authors:  Nurşen Yüksel; Yonca Anik; Aysun Kiliç; Vlevent Karabaş; Ali Demirci; Yusuf Cağlar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-13       Impact factor: 3.117

Review 3.  Vascular disease and cognitive impairment.

Authors:  Christiane Reitz; José A Luchsinger; Richard Mayeux
Journal:  Expert Rev Neurother       Date:  2008-08       Impact factor: 4.618

4.  White Matter Hyperintensity Associations with Cerebral Blood Flow in Elderly Subjects Stratified by Cerebrovascular Risk.

Authors:  Ahmed A Bahrani; David K Powell; Guoquiang Yu; Eleanor S Johnson; Gregory A Jicha; Charles D Smith
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-01-04       Impact factor: 2.136

5.  Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.

Authors:  Byung Hee Han; Meng-Liang Zhou; Fadi Abousaleh; Robert P Brendza; Hans H Dietrich; Jessica Koenigsknecht-Talboo; John R Cirrito; Eric Milner; David M Holtzman; Gregory J Zipfel
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

Review 6.  BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?

Authors:  Hemal Bhatt; Lama Ghazi; David Calhoun; Suzanne Oparil
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

Review 7.  Epidemiology of Alzheimer disease.

Authors:  Richard Mayeux; Yaakov Stern
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

8.  Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors.

Authors:  Michela Guglielmotto; Luca Giliberto; Elena Tamagno; Massimo Tabaton
Journal:  Front Aging Neurosci       Date:  2010-02-09       Impact factor: 5.750

9.  The association between small vessel infarcts and the activities of amyloid-β peptide degrading proteases in apolipoprotein E4 allele carriers.

Authors:  Haihao Zhu; Rafeeque A Bhadelia; Zhiheng Liu; Linh Vu; Huajie Li; Tammy Scott; Peter Bergethon; Mkaya Mwamburi; James L Rosenzweig; Irwine Rosenberg; Wei Qiao Qiu
Journal:  Angiology       Date:  2012-10-17       Impact factor: 3.619

Review 10.  Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.

Authors:  Hannah A D Keage; Roxanna O Carare; Robert P Friedland; Paul G Ince; Seth Love; James A Nicoll; Stephen B Wharton; Roy O Weller; Carol Brayne
Journal:  BMC Neurol       Date:  2009-01-13       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.